Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pulmonary Disease, Chronic Obstructive × Bronchoscopy × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Pulmonary Disease, Chronic Obstructive 1

Interventions

tocilizumab 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Immunoglobulin G 1 Iloprost 1 Educational Status 1 Disulfides 1 Bronchoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05411107 2024-05-17

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

National Cancer Institute (NCI)

Phase 2 Withdrawn

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡